Bit Discovery, Inc.

SANTA CLARA, CA · Founded 2018 · CIK 0001736597 · Biotech · Acquired

Proprietary stem cell reprogramming technology (opti-ox™) for converting stem cells into specified cell types at scale

bit.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$760K
1 Form D · Apr 2018
102 months since last filing
Contracts
—
No federal contracts on record
Patents
10
3 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$760,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2583Metagenomi——
2584PRAETEGO, INC.—$783K
2585Indigo Biosciences Inc.—$782K
2586Bit Discovery, Inc.—$760K
2587AAKHA BIOLOGICS INC.—$750K
2588ENDURE BIOTHERAPEUTICS, INC.——
2589ZIPPIN BIO CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Jeremiah GrossmanDirector · Executive Officer
  • Heather KonoldExecutive Officer
  • Susan MasonDirector

Patents

USPTO · 3 granted of 10

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.